Organ development is a complex process governed by the interplay of several signalling pathways that have critical functions in the regulation of cell growth and proliferation. Over the past years, the Hippo pathway has emerged as a key regulator of organ size. Perturbation of this pathway has been shown to play important roles in tumorigenesis. YAP, the main downstream target of the mammalian Hippo pathway, promotes organ growth, yet the underlying molecular mechanism of this regulation remains unclear. Here we provide evidence that YAP activates the mammalian target of rapamycin (mTOR), a major regulator of cell growth. We have identified the tumour suppressor PTEN, an upstream negative regulator of mTOR, as a critical mediator of YAP in mTOR regulation. We demonstrate that YAP downregulates PTEN by inducing miR-29 to inhibit PTEN translation. Last, we show that PI(3)K-mTOR is a pathway modulated by YAP to regulate cell size, tissue growth and hyperplasia. Our studies reveal a functional link between Hippo and PI(3)K-mTOR, providing a molecular basis for the coordination of these two pathways in organ size regulation.
as a central pathway regulating cell growth (cell size) by integrating intracellular and extracellular signals to stimulate protein translation 15 . As cell growth is required for proliferation, the function of the Hippo pathway is expected to be coordinated with TOR. Indeed, recent studies have provided evidence for a crosstalk between the Hippo and TOR pathways in Drosophila 16, 17 . However, the underlying molecular mechanism of this crosstalk has not been elucidated.
We investigated whether the canonical Hippo pathway affects mTOR signalling. We performed short interfering RNA (siRNA) knockdown of LATS1/2 in MCF10A cells and found that LATS1/2 knockdown decreased the level of YAP phosphorylation. Notably, LATS1/2 knockdown also resulted in the activation of mTOR complex 1 (mTORC1) and mTORC2, as evident in increased levels of phosphorylation of S6K Thr 389 and AKT Ser 473, which are direct substrates of mTORC1 and mTORC2, respectively (Fig. 1a) . Cell density is known to regulate YAP phosphorylation and activity 7 . Interestingly, high cell density also decreased the level of phosphorylation of S6K and AKT along with elevated YAP phosphorylation ( Supplementary Fig. S1a ). Subsequently, we examined the effects of YAP on mTORC1 and mTORC2 by generating stable MCF10A cells with YAP overexpression or YAP knockdown by short hairpin RNA (shRNA). As shown in Fig. 1b , overexpression of YAP increased the level of phosphorylation of both S6K Thr 389 and AKT Ser 473. Conversely, the level of phosphorylation at these residues was decreased in YAP knockdown cells, indicating that YAP regulates mTOR activity. Similar effects of YAP on mTOR activity were observed in HeLa cells ( Supplementary Fig. S1b ). We then investigated whether this regulation occurs in vivo using YAP transgenic mice 18 . Indeed, we observed an increase in the level of Ser 240/244 phosphorylation of the S6 ribosomal protein, the substrate of S6K, in the intestinal crypt compartment, which was the region with the highest YAP expression (Fig. 1c) , of the YAP transgenic mice. On the other hand, the crypt compartment of the control mice showed a much lower p-S6 signal. Furthermore, we observed an increase in the level of Ser 473 phosphorylation of AKT in the crypt compartment of the YAP transgenic mice (Fig. 1d) . Together, these data support a role for YAP in mTORC1/2 regulation.
Several cues such as nutrients, serum and growth factors can induce mTORC1 activation. We examined whether YAP depends on these factors to stimulate mTOR activity by performing serum starvation or amino acid starvation in control cells and YAP-overexpressing cells. Deprivation of serum or amino acid did not abolish the YAPinduced increase in the level of S6K phosphorylation ( Supplementary  Fig. S2a,b) . YAP is known to induce the expression of many genes, including growth factors 19 . To determine whether the effect of YAP on mTORC1 activity was due to extrinsic factors released into the media, we performed a media swap experiment between control cells and YAP-overexpressing cells. Media swap did not affect S6K phosphorylation in the respective cells ( Supplementary  Fig. S2c ), indicating that the YAP-induced mTORC1 activation was not dependent on extrinsic factors. Consistently, no difference in ERK1/2 phosphorylation was observed between YAP-overexpression and YAP-knockdown cells ( Supplementary Fig. S2d ).
To investigate whether YAP targets an already known component of the mTOR pathway, we examined the protein level of known upstream regulators of mTOR and of proteins that are in complex with mTOR. As shown in Fig. 2a , YAP overexpression or knockdown did not affect the protein expression of TSC2, AKT, mTOR, Raptor and Rictor. However, YAP overexpression decreased the protein level of the tumour suppressor PTEN (phosphatase and tensin homologue). Conversely, YAP knockdown increased the PTEN protein level. This YAPdependent regulation of PTEN was similarly observed in HeLa cells (Supplementary Fig. S1b ). Consistently, YAP-induced PTEN loss led to Supplementary Fig. S6 .
AKT activation, as indicated by increased levels of phosphorylation of GSK3 and FOXO1, two well-characterized AKT substrates (Fig. 2b) .
To determine whether PTEN was a critical target of YAP in activating mTOR, PTEN was ectopically expressed in YAP-overexpressing cells by transient transfection. In parallel, PTEN was knocked down in YAP-knockdown cells. Indeed, re-expression of PTEN antagonized the effects of YAP on mTORC1 and mTORC2 (Fig. 2c) . Conversely, knockdown of PTEN in YAP-knockdown cells rescued mTORC1 and mTORC2 activities (Fig. 2d) . Interestingly, in PTEN-null U87MG cells, YAP expression did not affect S6K phosphorylation ( Supplementary  Fig. S2e ). This YAP-dependent reduction of the PTEN protein level and the ability of PTEN to reverse the effects of YAP on mTORC1 and mTORC2 suggested that PTEN was a crucial mediator of YAP in the regulation of mTOR. Consistent with this, we found that inhibition of the phosphatidylinositol-3-OH kinase (PI(3)K)-AKT pathway by Wortmannin abolished the YAP-induced activation of mTORC1 and mTORC2 ( Supplementary Fig. S2f ). Furthermore, we found that YAP overexpression in the intestine correlated with significant downregulation of PTEN ( Fig. 2e and Supplementary Fig. S2g ).
It has recently been discovered that YAP phosphorylation is regulated by G-protein-coupled receptor (GPCR) signalling 20 . For example, thrombin, a ligand for the GPCR PAR1, induces YAP activation in MCF10A cells 21 . Therefore, we used thrombin as a stimulus to determine the physiological function of YAP in PTEN regulation. We found that thrombin treatment in MCF10A cells resulted in YAP activation and PTEN downregulation (Fig. 2f) . In the absence of YAP, Luciferase activities were assayed 48 h after transfection and normalized first to control miRNA and then to control luciferase (n = 3, mean + s.e.m.).
Data were obtained from three independent experiments. (e) miR-29c regulates the PTEN protein level. MCF10A cells were transiently transfected with precursor or inhibitor for miR-29c. Cell medium was changed the following day and lysates were collected four days later for immunoblotting. Cont, control. (f) YAP binds the promoter of miR-29c. ChIP was performed using anti-YAP and anti-IgG antibodies, followed by qPCR using primers specific to the indicated promoter regions (n = 3, mean + s.e.m.). Data were obtained from three independent experiments. (g) miR-29 mediates the effects of YAP on PTEN protein. Precursors and inhibitors for miR-29a/b/c were transiently transfected into the indicated stable cells. Cell medium was changed the following day, and cell lysates were collected after four days. (h) Expression of a miR-29 is sufficient to rescue the effects of YAP knockdown on S6K phosphorylation. The experiment was performed similarly to in g and lysates were collected six days later. Uncropped images of blots are shown in Supplementary Fig. S6 .
the effect of thrombin on PTEN was abolished. Collectively, these data establish a function for YAP in regulating PTEN. Previously, it has been reported that liver-specific knockout of Mst1/2 increases the level of S6K phosphorylation 22 . We therefore examined the status of PTEN in Mst1/2 −/− mice. Interestingly, we found that the level of PTEN expression was significantly reduced in the livers of Mst1/2 −/− mice and this correlated with YAP activation/dephosphorylation (Fig. 2g) , reinforcing a crosstalk between Hippo and PI(3)K-TOR through regulation of PTEN by YAP.
We sought to determine the mechanism through which YAP suppresses PTEN. As a transcription co-activator, YAP is known to induce gene transcription 23 . We examined the effect of YAP on PTEN transcription by quantitative real-time PCR with reverse transcription (RT-qPCR) and found that YAP overexpression or knockdown did not significantly alter the level of PTEN messenger RNA ( Supplementary Fig. S3a ). Subsequently, we examined the effects of YAP on PTEN protein stability and degradation by performing time-course experiments with S3d ), which has been reported to regulate PTEN protein stability 24 . As YAP affected neither PTEN transcription nor protein stability, we considered the possibility that YAP may regulate PTEN translation through microRNAs (miRNAs), which are important regulators of gene expression by inhibiting translation of their target mRNAs (ref. 25) . Previously, it has been reported that the Drosophila orthologue of YAP, Yorkie, induces the expression of the bantam miRNA that serves as a critical mediator of biological functions of Yorkie 26, 27 . Given the high conservation of the Hippo pathway, we investigated whether the YAP-induced PTEN reduction was mediated by miRNAs. First, we knocked down Dicer by siRNA in YAP-overexpressing cells. Interestingly, we found that Dicer knockdown restored PTEN expression in YAP-overexpressing cells (Fig. 3a) , suggesting that miRNAs are important for PTEN regulation by YAP. To determine whether YAP induces the expression of miRNAs, we used genome-wide deep-sequencing technology to identify potential miRNAs induced by YAP. Our data showed that YAP overexpression resulted in the upregulation of miRNAs, particularly the miR-29a/b/c family (Table 1 , see the accession number in Methods). Conversely, YAP knockdown resulted in the downregulation of miR-29a/b/c. The regulation of miR-29 expression by YAP was verified by RT-qPCR (Fig. 3b) . We also found that the levels of miR-29a/b/c were upregulated by thrombin (Fig. 3c) . Interestingly, thrombin downregulates the expression of these miRNAs in YAP-knockdown cells. Together, these data suggest a function of YAP in the regulation of miR-29.
The miR-29 family is predicted to target PTEN, as indicated by the presence of the miR-29a/b/c consensus site in the 3 untranslated region (UTR) of PTEN ( Supplementary Fig. S3e) . Recently, two studies have confirmed that miR-29a and miR-29b target PTEN to regulate cell migration 28, 29 . To determine whether miR-29c also regulates PTEN translation by targeting the 3 UTR of PTEN, we performed a luciferase assay with control miRNA or miR-29c. As shown in Fig. 3c , miR-29c reduced the level of a luciferase reporter that had the luciferase coding sequence fused with the PTEN 3 -UTR but did not affect the control reporter without the PTEN 3 -UTR. Moreover, when the putative binding sites for miR-29c were deleted, the miR-29c-induced decrease in luciferase reading was abolished (Fig. 3d) . Subsequently, we determined whether miR-29c regulates the PTEN protein by transiently inducing or inhibiting miR-29c in MCF10A cells. Transient overexpression or inhibition of miR-29c resulted in noticeable changes in PTEN protein levels (Fig. 3e) . Together, these data suggest that miR-29c downregulates PTEN protein by targeting the PTEN 3 -UTR.
We then investigated whether miR-29c is a direct target of YAP. Sequence analysis of the promoter region of miR-29c reveals putative binding sites for the TEAD transcription factors (Supplementary Fig.  S3f ), the main transcription factors mediating YAP functions 30, 31 . We performed chromatin immunoprecipitation (ChIP) with YAP antibody, followed by qPCR using primers for the miR-29c promoter. Our data showed that YAP did bind the promoter region of miR-29c, particularly the region 150-300 base pairs upstream of the transcription start site that harbours a TEAD consensus site (Fig. 3f) . CTGF, a known target gene of YAP-TEAD, and GAPDH were used as positive and negative controls, respectively. Thus, YAP seems to directly induce miR-29c to target PTEN. The promoters of miR-29a and miR-29b1/2 also contain binding sites for TEADs (Supplementary Fig. S3f ), suggesting that YAP transcriptionally regulates miR-29 to inhibit PTEN. Consistent with our observations, an inverse correlation between PTEN and miR-29 has been reported in hepatocellular carcinoma 29 . To confirm the role of miR-29 in the regulation of PTEN by YAP, we transiently overexpressed each miR-29 in YAP-knockdown cells and in parallel transiently inhibited each miR-29 in YAP-overexpressing cells. We found that manipulation of a single miR-29 was sufficient to alter the effects of YAP overexpression or YAP knockdown on PTEN (Fig. 3g) . Furthermore, each miR-29 is sufficient to rescue the effects of YAP knockdown on phosphorylation of S6K and S6 (Fig. 3h) . These data support that the miR-29 family is important for the regulation of PTEN by YAP.
We investigated the physiological relevance of YAP-induced mTOR activation through PTEN. We observed that YAP overexpression increased cyclin D1 expression (Supplementary Fig. S4a ). Subsequently, we examined whether YAP regulates cell size. We cultured stable MCF10A cells to ∼40% confluence, then performed overnight serum starvation to synchronize cells, and analysed cell size by flow cytometry using forward scatter. Our data showed that cell size was increased in YAP-overexpressing cells and more significantly in the constitutively active YAP-5SA-expressing cells (Fig. 4a) . Interestingly, the YAPinduced increase in cell size was mimicked by PTEN knockdown (Fig. 4b) . To determine whether mTOR mediates YAP-induced increase in cell size, we inhibited mTOR activity by rapamycin in control cells and YAP-overexpressing cells. We found that rapamycin treatment indeed abolished the YAP-induced increase in cell size, and the corresponding histogram of YAP-overexpressing cells with rapamycin treatment overlapped with that of control cells with rapamycin treatment (Fig. 4c) . Similarly, treatment with LY294002, which also inhibits mTOR through inhibition of PI(3)K, abolished the effect of YAP on cell size (Fig. 4d) . We also determined whether YAP regulates cell size in vivo using transgenic mice with YAP overexpression in the skin 32 . We found that the size of keratinocytes in the YAP transgenic mice was significantly larger when compared with that in control mice (Fig. 4e) . Together, these data demonstrate a function of YAP in cell size regulation in a manner dependent on PI(3)K-mTOR. Although transient overexpression of miR-29 positively contributes to mTOR activity (Fig. 3h) , we did not observe a detectable effect of miR-29 on cell size, possibly owing to a weak activation of mTOR from transient overexpression of miR-29.
Last, we determined the functional significance of the Hippo-PI(3)K-mTOR crosstalk in vivo. It has been reported that YAP overexpression in the skin leads to tissue expansion and hyperplasia 32 . Notably, we found that YAP overexpression in the skin resulted in mTOR activation (Fig. 4f) . Interestingly, we also observed a downregulation of the PTEN protein in the YAP transgenic mice (Fig. 4g) . Therefore, we performed LY294002 treatment in control mice and YAP transgenic mice. As shown in Fig. 4f , activation of YAP under the K14-Cre promoter resulted in thickening and hyperplasia of the epidermis and the tongue. The extent of hyperplasia was reduced following inhibition of the PI(3)K pathway in the YAP transgenic mice (Fig. 4h) , suggesting that the PTEN axis is an important component contributing to YAP-driven tissue overgrowth in vivo. Consistently, a decreased level of phosphorylation of S6 confirmed the inhibition of mTOR in the YAP transgenic mice by LY294002 (Fig. 4i) , and correlated with a reduction of YAP-induced overgrowth and hyperplasia (Fig. 4h) . These findings suggest that PI(3)K-mTOR is a pathway modulated by YAP to drive tissue expansion.
Our studies establish a functional link between Hippo and TOR, the two major regulators of organ size. Coordination between these two pathways is expected given the function of YAP in cell proliferation, which cannot be sustained without cell growth. This report provides a molecular mechanism through which the Hippo pathway regulates cell growth via TOR. YAP mediates the main effects of the Hippo pathway by regulating gene expression, and among the YAP target genes is the miR-29 family, which inhibits PTEN by targeting its 3 -UTR. PTEN is a key antagonist of PI(3)K, which is well established as an upstream activator of mTOR. Hence, the Hippo pathway inhibits cell growth by inactivating the mTOR pathway (both mTORC1 and mTORC2), and this is executed at least in part through the actions of YAP, miR-29 and PTEN, subsequently affecting AKT, TSC1/2 and Rheb ( Supplementary Fig. S5 ). When organ growth is needed the Hippo pathway will be inactivated, which leads to YAP activation and gene expression-such as miR-29 to promote cell growth and cyclin D1 to induce proliferation-resulting in the eventual increase in organ size.
The functional regulation of PTEN by YAP revealed in this study has important implications in growth control and cancer biology. PTEN is a key negative regulator of the cell-survival signalling pathway initiated by PI(3)K, whose activation is triggered by ligand binding to receptor tyrosine kinases. mTOR functions as a nutrient sensor that integrates PI(3)K-mediated growth factor signalling to regulate cell growth. The recent discovery of the Hippo pathway as a downstream signalling branch of GPCRs suggests that a wide range of secreted signals could modulate growth through the Hippo pathway. The link from YAP to PTEN to mTOR reveals a possible integration of GPCRs, receptor tyrosine kinases and nutrient status in growth control, illustrating how a web of signalling networks coordinate with each other to fine-tune physiological and pathological processes. Given the prominent roles of both YAP and PTEN in tumorigenesis, it would be interesting to explore the interplay of these genes in human cancers.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
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Cell culture and lentiviral infections. All cell lines were maintained at 37 • C with 5% CO 2 . MCF10A cells were cultured in DMEM/F12 (Invitrogen) supplemented with 5% horse serum (Invitrogen), 20 ng ml −1 EGF, 0.5 µg ml −1 hydrocortisone, 10 µg ml −1 insulin, 100 ng ml −1 cholera toxin and 50 µg ml −1 penicillin/streptomycin. All other cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. Cells stably expressing PQCX1H empty vector, YAP and YAP-5SA were generated by retroviral infection as previously described 7 . For lentiviral infection, HEK293T cells were transfected with lentiviral constructs and packaging plasmids (psPAX2 and pMD2.G). Forty-eight hours after transfection, the lentiviral supernatant was supplemented with 0.5 µg ml −1 Polybrene, filtered through a 0.45-µM filter and used to infect target cells. YAP and PTEN shRNAs were described previously (refs 30 and 33, respectively) .
Antibodies. The following antibodies were purchased from Santa Cruz Biotechnology: YAP (sc-15407, 1:500), GAPDH (sc-20357, 1:1,000), and TSC2 (sc-893, 1:200). Dicer antibody was purchased from Abcam (ab-13D6, 1:200). The following antibodies were purchased from Cell Signaling Technology: S6K (#9202L, 1:1,000), phospho-S6K (#9234L, 1:1,000), AKT (#9272, 1:1,000), phospho-AKT Ser 473 (#4058S, 1:1,000), GSK3α (#9338, 1:1,000), p−GS6K3α/β (#9331L, 1:1,000), PTEN (#9552, 1:1,000), phospho-PTEN (#9554S, 1:1,000), p-YAP (#4911, 1:1,000), Raptor (#2280, 1:1,000), Rictor (#2140, 1:1,000), mTOR (#2972, 1:1,000), FoxO1 (#9462, 1:1,000), p-FoxO1 (#9461, 1:000), S6 (#2217S, 1:1,000), phospho-S6 (#2215S, 1:1,000), Lats (#3477S, 1:1,000) and Mst1 (#3682S, 1:1,000). Tubulin antibody (T5326, 1:8,000) was purchased from Sigma Aldrich.
Chemicals. Thrombin was purchased from Enzyme Research Laboratories.
Wortmannin and LY294002 were purchased from Sigma-Aldrich. YAP intestinal overexpression. As previously described 4 , tetracycline-inducible YAP S127A male mice, 4-6 weeks in age, were given doxycycline (1 mg ml −1 ) ad libitum in their drinking water. These mice contain a single allele for YAP S127A in the collagen A1 locus and the M2-reverse tetracycline transactivator in the Rosa26 locus. Mice were euthanized five days after induction by carbon dioxide inhalation followed by cervical dislocation. Intestines were removed from the animals and fixed in 4% paraformaldehyde in PBS at 4 • C overnight. Intestines were then washed in PBS the following day before embedding for paraffin sectioning. Three separate animals were examined and produced similar results. This protocol was approved by an AAALAC-accredited animal facility.
Fluorescent immunohistochemical staining.
Tissue slides were deparaffinized/hydrated by consecutive washes with xylene (10 min, 2×), 100% ethanol (10 min, 2×), 95% ethanol (5 min, 1×), 80% ethanol (5 min, 1×), 70% ethanol (5 min, 1×) and PBS (10 min, 2×). Slides were placed in a beaker containing 10 mM sodium citrate (pH 6.0), boiled for 5 min in a microwave, and then cooled for 30 min at room temperature. Sections were washed three times with PBS, blocked with 5% goat serum for 1 h at room temperature and incubated overnight at 4 • C with anti-YAP (sc-101199, 1:50, Santa Cruz Biotechnology), anti-phospho-S6 (#2215S, 1:75, Cell Signaling), anti-phospho-AKT (#4058S, 1:50, Cell Signaling) or anti-PTEN (#9559, 1:50, Cell Signaling) antibodies. Sections were washed three times with TBST (Tris-buffered saline, at pH 7.4, with 0.05% Tween) and incubated with Alexa Fluor-488 or -594 secondary antibodies (Invitrogen). Sections were washed three times with TBST, and mounted onto slides using ProLong Gold antifade reagent with DAPI (Invitrogen). Immunofluorescence signal was detected using Olympus confocal microscopy.
RNA isolation and real-time PCR.
Total RNA was isolated from cells using Trizol reagent (Invitrogen). Complementary DNA was synthesized by reverse transcription using random hexamers and subjected to real-time PCR with gene-specific primers in the presence of Cybergreen (Applied Biosystems). Relative abundance of mRNA was calculated by normalization to hypoxanthine phosphoribosyltransferase 1 (HPRT) mRNA.
TaqMan miRNA assay. miRNA-enriched RNA was isolated using the miRNeasy Mini Kit (Qiagen). Mature miRNA was detected by TaqMan MicroRNA Assay (Applied Biosystems). Relative abundance of mature miRNA was calculated by normalization to Rnu6b (Applied Biosystems).
Small RNA library construction for deep sequencing. Total RNA was sizefractionated on a 15% Tris-borate-EDTA urea polyacrylamide gel. The RNA fragments of length 15-50 nucleotides were isolated, quantified following gel elution, and ethanol precipitated. The SRA 5 adapter (Illumina) was ligated to the aforementioned RNA fragments with T4 RNA ligase (Promega). The ligated RNAs were size-fractionated on a 15% Tris-borate-EDTA urea polyacrylamide gel and the RNA fragments of size ∼41-76 nucleotides were isolated. The SRA 3 adapter (Illumina) ligation was then performed, followed by a second size-fractionation using the same gel conditions as described above. The RNA fragments of size ∼64-99 nucleotides were isolated through gel elution and ethanol precipitation. Next, the ligated RNA fragments were reverse transcribed to single-stranded cDNAs using M-MLV (Invitrogen) with RT-primers recommended by Illumina. The cDNAs were amplified with pfx DNA polymerase (Invitrogen) in 20 cycles of PCR using Illumina's small RNA primers set. Finally, PCR products were purified on a 12% TBE polyacrylamide gel and a slice of gel of ∼80-115 base pairs was excised. This fraction was eluted and the recovered cDNAs were precipitated and quantified on a NanoDrop spectrophotometer (Thermoscientific) and on TBS-380 mini-fluorometer (Turner Biosystems) using Picogreen double-stranded DNA quantization reagent (Invitrogen). The concentration of the sample was adjusted to ∼10 nM and a total of 10 µl was used in the sequencing reaction. Luciferase assay. HEK293T cells were seeded in 12-well plates. Control miRNA and miR-29c precursors (Ambion) were transfected using Lipofectamine 2000 reagent (Invitrogen) following the manufacturer's protocol. PGL3 control luciferase and PGL3 wild-type PTEN 3 -UTR luciferase plasmids were obtained from Addgene. PGL3-mut PTEN 3 -UTR was generated by Quikchange Site-Directed Mutagenesis with deletion of the putative miR-29c binding site in the 3 -UTR of PTEN. Luciferase assay was performed 48 h after transfection using the Dual Glo Luciferase System (Promega). All luciferase activities were normalized to Renilla. miRNA precursors and inhibitors. Pre-miRNA precursors and anti-miRNA inhibitors were purchased from Ambion. Precursors and inhibitors were doublestranded and single-stranded RNA molecules, respectively, designed to mimic endogenous miRNAs or inhibit mature miRNAs from functioning. Transfection was done in MCF10A cells using Lipofectamine 2000 reagent (Invitrogen) following the manufacturer's protocol. miRNA stem loop sequence: mir-29a, 5 -AUGACUGAUUUCUUUUGGUGUUC-AGAGUCAAUAUAAUUUUCUAGCACCAUCUGAAAUCGGUUAU-3 ; miR29b, 5 -CUUCAGGAAGCUGGUUUCAUAUGGUGGUUUAGAUUUAAAUAGU-GAUUGUCUAGCACCAUUUGAAAUCAGUGUUCUUGGGGG-3 ; miR-29c, 5 -AUCUCUUACACAGGCUGACCGAUUUCUCCUGGUGUUCAGAGUCUGUU-UUUGUCUAGCACCAUUUGAAAUCGGUUAUGAUGUAGGGGGA-3 . Mature miRNA sequence: miR-29a, 5 -UAGCACCAUCUGAAAUCGGUUA-3 ; miR-29b, 5 -UAGCACCAUUUGAAAUCAGUGUU-3 ; miR-29c, 5 -UAGCACCA-UUUGAAAUCGGUUA-3 .
ChIP. MCF10A cells were crosslinked with 1% formaldehyde (Sigma) and chromatin DNA was sheared to 300-800 base pairs in average size through sonication. On day 1, sheep anti-rabbit magnetic beads (Invitrogen/Dynal) were pre-washed three times with 5 mg ml −1 BSA/PBS and incubated with 10 µg of YAP (sc-15407, Santa Cruz Biotechnology) or normal rabbit IgG (sc-2027, Santa Cruz Biotechnology) on a rotating platform overnight at 4 • C. On day 2, beads were washed three times, and immunoprecipitation reactions were carried out with crude extracts overnight at 4 • C in a solution containing 1% Triton X-100, 0.1% sodium deoxycholate, 1× Complete protease inhibitor, and 1× TE (10 mM Tris, at pH 8.0, and 1 mM EDTA). Five per cent of the crude extract was set aside for input. On day 3, beads were washed eight times with RIPA buffer (50 mM HEPES, at pH 8.0, 1 mM EDTA, 1% NP-40, 0.7% sodium deoxycholate, dH 2 O, 0.5M LiCl and 1× Complete protease inhibitor) and once with TE. After removal of TE by aspiration, tubes were centrifuged for 3 min at 1,500g and any remaining liquid was removed with a pipette. Beads were resuspended in elution buffer (10 mM Tris, at pH 8.0, 1 mM EDTA, 1% SDS and dH 2 O) and incubated at 65 • C for 10 min with frequent mixing. Tubes were then centrifuged for 30 sec at 15,700g and supernatants were transferred into new tubes. Elution buffer was added and reverse crosslinking reactions were carried out overnight at 65 • C. On day 4, proteinase K solution (140 µl TE, 3 µl of 10 mg ml −1 glycogen and 7 µl of 20 mg ml −1 proteinase K) was added to samples, and tubes were incubated for 2 h at 37 • C, followed by two phenol extractions and one chloroform/isoamyl alcohol extraction. DNA was ethanol-precipitated and resuspended in TE containing 10 µg of RNAse A. The mixture was incubated for 1 h at 37 • C, and purified using the Qiagen PCR purification kit. DNA was eluted and stored at −20 • C.
Flow cytometry. Live cells (7-AAD − ) were gated and analysed for size by FSC median fluorescence intensity (MFI) on a BDFacscalibur (BD Biosciences). In the case of dsRed-expressing cells (shPTEN 1 and shPTEN 2, Fig. 4b ), single cells were stratified into dsRed − and dsRed + populations on the basis of comparison with staining controls and size quantified using the FSC median fluorescence intensity. Data were acquired and analysed using BD CellQuest Pro and FlowJo (Tree Star) software.
LY294002 animal experiment.
For in vivo administration of LY294002, YAP S127A (YAP Tg) K14-Cre mice 5 (male), at the age of 5 weeks, were treated with either LY294002 (Sigma Chemical) or the vehicle control (dimethylsulphoxide/PBS). LY294002 (50 mg kg −1 in dimethylsulphoxide/PBS) or dimethylsulphoxide/PBS alone was administered to the mice by intraperitoneal injection every other day for a total of 5 injections. The day after the first LY294002 injection, doxycycline (1 g l −1 ) induction was started for a total of 8 days leading to overexpression of the constitutively active form of YAP (YAP S127A ) in the epidermis. The day after the last LY294002 or vehicle injection (8 days on doxycycline), the mice were euthanized and the shaved skin of the back and the tongue were isolated. For immunohistochemical analysis, back skin and tongue were fixed in 4% paraformaldehyde in PBS overnight at 4 • C and embedded in paraffin. Sectioned slides were stained with haematoxylin and eosin. For cell size analysis, back skin was incubated floating on 0.25% trypsin-EDTA with the epidermis facing up at 4 • C overnight, which allowed for separation of the epidermis from the dermis the following morning. The epidermis was minced, resuspended in cold PBS and filtered (40 µm), resulting in a single-cell suspension of primary keratinocytes. The primary keratinocytes were analysed with a BD Biosciences FACSCalibur flow cytometer. Events were gated according to forward scatter and side scatter to exclude debris and aggregates and plotted as a forward-scatter histogram to evaluate cell size. All animal procedures were approved by the Children's Hospital Boston Institutional Animal Care and Use Committee.
Mst1/2 liver knockout. All of the 3 wild-type liver samples were obtained from 7-week-old wild-type mice (2 males and 1 female). The Mst 1/2 −/− liver samples were collected from AlbuminCre Mst 1 −/− ;Mst 2 floxed/floxed mice 6 . The gender and age of mice were as follows: #1, male, 7-week-old at euthanization; #2, female, 7-week-old at euthanization; and #3, male, 14-week-old at euthanization. All mice (wild-type and Mst 1/2 −/− ) were maintained on a mixed genetic background (C57BL/6;129SV 
